mark'ennovy Archives - Page 2 of 4 - mark'ennovy
Proud to be part of the EYE European Project
At mark’ennovy, we’re passionate about the future of vision and this is why we are 100% committed to science and innovation in every way. We are invested in vision’s continuous improvement and we are proud to support various organizations and universities whose main fields of research relate to contact lenses. One such project that we’re […]
19
September 2022
Strategies to increase contact lens wear satisfaction
As we saw in our previous blog post, the main reasons1 for contact lens dropout in the presbyopic population are: Also, studies2-4 have shown that the reasons for dropping out vary slightly depending on the amount of time that the patient has been wearing contact lenses. These findings suggest that eye care professionals should have […]
12
August 2022
Multifocal and Multifocal Toric soft contact lenses with 25 years of experience
In 2022, mark’ennovy celebrates its 25th anniversary. In 1997, Georges Sarrouf founded the company in Madrid, specialising in bespoke, conventional contact lenses and, 25 years later, is still at the helm as CEO. The company has become a market leader for the manufacture of individually crafted contact lenses. Continuous innovation and advancement define our corporate culture. This […]
7
July 2022
Meet The Team: Talking Quality Assurance and Regulatory Affairs With Mercedes Lopez
A business is only as good as its employees – and we have very good employees! As part of our 25th anniversary celebrations, we’re going ‘behind the scenes’ to talk to different members of the team in order to learn more about the importance of their roles within the company and the important contribution they […]
25
May 2022
Meet The Team: Talking MDR With Mercedes Lopez
This is the second part of the Meet The Team: Mercedes López Bellón series where she talks about MDR regulation. If you have not read the first part, we invite you to start with that article. Can you explain MDR? “The new MDR (Medical Device Regulation) is a new regulation that came into force on […]
25
May 2022
What efficacy can we expect of MYLO after one year of use?
A study looks at the efficacy of MYLO: a monthly disposable silicone hydrogel contact lens designed with BHVI‘s patented EDOF technology to slow the progression of myopia. EDOF technology has previously been studied in terms of visual performance and efficacy in slowing myopic progression. Also, some data on short-term visual effects of MYLO have recently […]
23
May 2022
Analysing Dropout to Understand Contact Lens Wear Satisfaction
As we saw in our previous blog post, contact lens usage dramatically decreases around age 40. Maybe it is worth taking the time to analyse why this happens. This critical age overlaps with the beginning of presbyopia for several patients, so this is essentially related to multifocal and multifocal toric contact lenses. Patients may start […]
25
April 2022
The New, Updated My’Ennovy Portal
The My’Ennovy portal has long been a useful tool in most of our customers’ toolkits. In recent months, we’ve been working hard to redesign the My’Ennovy portal making it even better and more helpful. We’re proud to introduce the NEW My’Ennovy portal: it’s simple, modern and, most importantly, useful. The portal has been streamlined, with […]
7
March 2022
The Moment for Presbyopia
Around 20% of the world´s population is presbyopic, but only 8% wear contact lenses as their primary mode of correction. Learn about presbyopia in this post! What is Presbyopia? Presbyopia is a gradual reduction of the eye’s ability to focus accurately on near objects. It starts to affect vision at around 40 years. Near and […]
2
March 2022
MULTIFOCAL TORIC CONTACT LENSES: DEBUNKING MYTHS. PART 2
WHAT IS THE MINIMUM AMOUNT OF ASTIGMATISM THAT SHOULD BE CORRECTED? With a contact lens, astigmatism of -0.75 dioptres would have to be corrected. If only the sphere was to be corrected, -0.50 dioptres would be the amount that could be left uncorrected with the patient still having an optimal visual acuity. This is true […]
2
March 2022